New R01 funded: CABARET (Cabotegravir PrEP)

grant

Published

September 23, 2022

Received notice of award from NIH/NIAID for a new collaborative project led by PI Julia Marcus at Harvard Medical School: Cabotegravir PrEP: Actionable Robust Evidence for Translation into Practice (R01 AI174862). The study evaluates the real-world use, clinical outcomes, and optimal investment of resources for long-acting injectable PrEP.